Respiratory virus coinfections during the COVID-19 pandemic: epidemiologic analysis and clinical outcomes from the Phase 2/3 molnupiravir trial (MOVe-OUT)Research Article Published on 2024-03-012024-09-05 Journal: Microbiology Spectrum [Category] update2024, [키워드] COVID-19 Epidemiology molnupiravir Respiratory pathogens [DOI] 10.1128/spectrum.03563-23 PMC 바로가기 [Article Type] Research Article
Determining and Comparing the Real-World Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Patients Hospitalized With COVID-19Original Article Infectious Diseases Published on 2024-02-192024-09-05 Journal: Journal of Korean medical science [Category] update2024, [키워드] COVID-19 COVID-19 drug treatment molnupiravir Nirmatrelvir [DOI] 10.3346/jkms.2024.39.e52 PMC 바로가기 [Article Type] Original Article Infectious Diseases
The effectiveness of oral anti-SARS-CoV-2 agents in non-hospitalized COVID-19 patients with nonalcoholic fatty liver disease: a retrospective studyPharmacology Original Research Published on 2024-02-152024-09-05 Journal: Frontiers in Pharmacology [Category] update2024, [키워드] COVID-19 molnupiravir nirmatrelvir plus ritonavir Nonalcoholic Fatty Liver Disease outcome [DOI] 10.3389/fphar.2024.1321155 PMC 바로가기 [Article Type] Pharmacology Original Research
Real-World Effectiveness Study of Nirmatrelvir-Ritonavir or Molnupiravir in Hospitalized Unvaccinated Patients with Chronic Respiratory Diseases and Moderate COVID-19 at PresentationOriginal Research Published on 2024-01-092024-09-05 Journal: International journal of chronic obstructive pulmo [Category] update2024, [키워드] Asthma bronchiectasis COPD COVID-19 Interstitial lung disease molnupiravir Nirmatrelvir-ritonavir [DOI] 10.2147/COPD.S440895 PMC 바로가기 [Article Type] Original Research
Genetic consequences of effective and suboptimal dosing with mutagenic drugs in a hamster model of SARS-CoV-2 infectionResearch Article Published on 2024-01-042024-09-05 Journal: Virus Evolution [Category] update2024, [키워드] Favipiravir molnupiravir Mutagenesis SARS-CoV-2 [DOI] 10.1093/ve/veae001 PMC 바로가기 [Article Type] Research Article
Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistanceAntiviral Agents Published on 2024-01-042024-09-05 Journal: Med Instrum [Category] update2024, [키워드] antiviral resistance COVID-19 molnupiravir N-hydroxycytidine [DOI] 10.1128/aac.00953-23 PMC 바로가기 [Article Type] Antiviral Agents
Effectiveness of Vaccines and Antiviral Drugs in Preventing Severe and Fatal COVID-19, Hong KongResearch Published on 2024-01-012024-09-05 Journal: Emerging Infectious Diseases [Category] update2024, [키워드] Comirnaty CoronaVac coronavirus coronavirus disease COVID-19 Hong Kong molnupiravir Nirmatrelvir respiratory infections Ritonavir SARS SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 viruses zoonoses [DOI] 10.3201/eid3001.230414 PMC 바로가기 [Article Type] Research
SARS-CoV-2 infection in solid organ transplant recipients: Experience with molnupiravirarticle Published on 2023-11-272024-09-05 Journal: Revista española de quimioterapia : publicación [Category] update2024, [키워드] COVID-19 molnupiravir transplantation [DOI] 10.37201/req/s01.06.2023 PMC 바로가기 [Article Type] article
COVID -19: On the threshold of the fifth year. The situation in SpainReview Published on 2023-11-272024-09-05 Journal: Revista española de quimioterapia : publicación [Category] update2024, [키워드] antivirales antivirals COVID-19 Gripe Influenza Mascarillas Masks molnupiravir Nirmatrelvir-ritonavir recombinant variants Remdesivir SARS-CoV2 Vaccines vacunas variantes recombinantes [DOI] 10.37201/req/123.2023 PMC 바로가기 [Article Type] Review
Effectiveness and Adverse Events of Nirmatrelvir/Ritonavir Versus Molnupiravir for COVID-19 in Outpatient Setting: Multicenter Prospective Observational StudyOriginal Article Published on 2023-10-302024-09-05 Journal: Journal of Korean medical science [Category] update2024, [키워드] COVID-19 molnupiravir Nirmatrelvir and Ritonavir Drug Combination [DOI] 10.3346/jkms.2023.38.e347 PMC 바로가기 [Article Type] Original Article